ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,718.57
      0.28%
      US Tech 100
      19,312.80
      0.08%
      Dow Jones
      42,124.65
      0.15%
      Brent Oil
      73.525
      -0.28%
      Bitcoin
      63,293.47
      -0.05%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Canada
      5. TSX

      6. Resverlogix Corp (RVX) Quote

      Resverlogix Corp

      Resverlogix Corp (RVX)

      TSX
      0.065
      0.00
      (0.00%)
      Closed September 23 4:12PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.065
      Bid
      0.065
      Ask
      0.07
      Volume
      2,000
      0.065 Day's Range 0.07
      0.04 52 Week Range 0.095
      Market Cap
      17.704M
      Previous Close
      0.065
      Open
      0.07
      Last Trade
      1000
      @
      0.065
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      86,484
      Shares Outstanding
      272,371,000
      Dividend Yield
      -
      PE Ratio
      -0.98
      Earnings Per Share (EPS)
      -0.06
      Revenue
      57k
      Net Profit
      -16.74M

      About Resverlogix Corp

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.resverlogix.com
      Headquarters
      Calgary, Alberta, Can
      Founded
      -
      Resverlogix Corp is listed in the Biological Pds,ex Diagnstics sector of the Toronto Stock Exchange with ticker RVX. The last closing price for Resverlogix was $0.07. Over the last year, Resverlogix shares have traded in a share price range of $ 0.04 to $ 0.095.

      Resverlogix currently has 272,371,000 shares outstanding. The market capitalization of Resverlogix is $17.70 million. Resverlogix has a price to earnings ratio (PE ratio) of -0.98.

      Ask ADVFN Intelligence (AI)

      RVX Latest News

      More News

      InvestmentPitch Media Video Discusses Resverlogix and its Focus on Apabetalone’s Future Development for the Prevention and Treatment of Post COVID-19 Conditions

      VANCOUVER, British Columbia, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. (TSX:RVX) (OTCPink:RVXCF), a world leader in epigenetics, or gene regulation, announced that apabetalone’s...

      September 30 2022
      GlobeNewswire Inc.

      Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

      CALGARY, Alberta, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) today announced that apabetalone’s future clinical development related to...

      September 28 2022
      GlobeNewswire Inc.

      Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease

      CALGARY, Alberta, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “Reduction in the Risk of Major Adverse...

      August 22 2022
      GlobeNewswire Inc.

      Resverlogix Announces Appointment of New Chief Scientific Officer

      CALGARY, Alberta, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the appointment of Dr. Ewelina Kulikowski, Ph.D. as Chief Scientific Officer. Dr...

      August 15 2022
      GlobeNewswire Inc.

      Resverlogix Announces Voting Results from the 2022 Meeting of Shareholders

      CALGARY, Alberta, June 21, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix”, or the "Corporation") (TSX:RVX) today held its Annual Meeting of Shareholders (the “Meeting”) in Calgary...

      June 21 2022
      GlobeNewswire Inc.

      Resverlogix Announces New Research Findings Highlighting the Safety of BD2-selective BET Inhibitors

      CALGARY, Alberta, June 08, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “Breaking boundaries: Pan BETi disrupt 3D...

      June 08 2022
      GlobeNewswire Inc.

      Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-risk COVID-19 Outpatient Study

      CALGARY, Alberta, May 09, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix", or "the Company") (TSX:RVX), in partnership with EVERSANA™, today announced that the U.S. Food and Drug...

      May 09 2022
      GlobeNewswire Inc.

      Resverlogix Announces One-Year Extension of Debenture

      CALGARY, Alberta, April 19, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the “Company”) (TSX:RVX) announced today that it has closed a one-year extension of Company’s US$6.0...

      April 19 2022
      GlobeNewswire Inc.

      Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine

      CALGARY, Alberta, March 17, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) today announced the publication of an article entitled “BET Protein Inhibition for Pulmonary...

      March 17 2022
      GlobeNewswire Inc.

      Resverlogix Corp. to Webcast Live at VirtualInvestorConferences.com March 10th

      CALGARY, Alberta, March 09, 2022 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix") (TSX:RVX), a global leader in the development of epigenetic therapeutics, today announced that Donald...

      March 09 2022
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1000.0650.070.065404410.065CS
      4-0.025-27.77777777780.090.0950.061139380.08277866CS
      120.015300.050.0950.04864840.07743673CS
      260.0058.333333333330.060.0950.04557090.07092482CS
      52-0.01-13.33333333330.0750.0950.04507900.06914165CS
      156-0.545-89.34426229510.610.820.04661460.2127869CS
      260-2.585-97.54716981132.652.650.04743750.60673441CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AXISAxis Auto Finance Inc
      $ 0.015
      (50.00%)
      		11k
      VRTSVertiqal Studios Corporation
      $ 0.02
      (33.33%)
      		1.24M
      QECQuesterre Energy Corporation
      $ 0.28
      (24.44%)
      		146.31k
      APLIAppili Therapeutics Inc
      $ 0.03
      (20.00%)
      		9.25k
      FSYForsys Metals Corp
      $ 0.68
      (15.25%)
      		316k
      CEMXCematrix Corp
      $ 0.245
      (-22.22%)
      		5.85M
      FLNTFlint Corporation
      $ 0.025
      (-16.67%)
      		37.5k
      MINExcelsior Mining Corp
      $ 0.115
      (-14.81%)
      		1.01M
      IVQInvesque Inc
      $ 0.15
      (-14.29%)
      		8.55k
      XLYAuxly Cannabis Group Inc
      $ 0.035
      (-12.50%)
      		332.22k
      CNQCanadian Natural Resources Ltd
      $ 45.67
      (0.93%)
      		16.76M
      TRPTC Energy Corporation
      $ 63.64
      (1.58%)
      		13.77M
      TDToronto Dominion Bank
      $ 86.32
      (-1.40%)
      		9.17M
      DMLDenison Mines Inc
      $ 2.37
      (3.95%)
      		8.29M
      SUSuncor Energy Inc
      $ 51.13
      (1.31%)
      		7.84M

      RVX Discussion

      View Posts
      alvaroc2 alvaroc2 8 years ago
      TA breaking 2,50 try 3 $.
      👍️0
      alvaroc2 alvaroc2 8 years ago
      No analist cover at the moment, when news came.....
      👍️0
      alvaroc2 alvaroc2 8 years ago
      Good evening clase 2,41 near high 2,47,good news and many conferences in march and april.
      👍️0

      Your Recent History

      TSX
      RVX
      Resverlogix
      Delayed Upgrade Clock